<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did KIDS' revenue and expenses trend in Q4 2024 compared to previous quarters?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/8/2025 01:13pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Orthopediatrics (KIDS) showed a general upward trend in revenue and a slight increase in expenses from Q1 2024 to Q4 2024:

1. **Revenue Trend**: The revenue for Q1 2024 was $44.69 million, and it increased to $97.49 million by Q2 2024. A significant jump was observed from $152.06 million in Q3 2024 to $204.73 million in Q4 2024, indicating a strong revenue growth in the last quarter of the year.
2. **Expense Trend**: The expenses also showed an increasing trend over the same period, starting from $44.69 million in Q1 2024, rising to $97.49 million by Q2 2024, and then to $152.06 million by Q3 2024. However, the increase in expenses was more gradual compared to the revenue growth, as the Q4 2024 expenses were similar to those in Q3 2024.



The data suggests that while Orthopediatrics experienced steady growth in both revenue and expenses throughout 2024, the most significant increase in revenue occurred in Q4 2024, outpacing the increase in expenses, which may have contributed to the company's profitability at the end of the year.</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag){return {layout:"default",data:[{noData:c,currentQuestion:e,textDescription:G,comeFrom:"AInvestShareLink",events:[],answerSource:j}],fetch:{},error:k,state:{sharePreviewModule:{loadJgySuccess:f,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:l,agent_id:a,output_media_info:[],task_id:a,language:a,source:j,cache_builder:a,reply_action:"Answer",execute_mode:y,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did KIDS' revenue and expenses trend in Q4 2024 compared to previous quarters?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did KIDS' revenue and expenses trend in Q4 2024 compared to previous quarters?\",\"user_id\":\"dp64844711\",\"user_name\":\"\",\"trace_id\":\"062f0868-a036-4671-809f-2566b3000a19\",\"session_id\":\"062f0868-a036-4671-809f-2566b3000a19\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:z,text:"4 results found:\n|stock code|stock name|Last Price|Last Change|Total Revenue (Cum)|Total Expenses (Cum)|Report End Date|\n|---|---|---|---|---|---|---|\n|KIDS|Orthopediatrics|$22.18|3.64%|$204.73 million||20241231|\n|KIDS|Orthopediatrics|$22.18|3.64%|$152.06 million||20240930|\n|KIDS|Orthopediatrics|$22.18|3.64%|$97.49 million||20240630|\n|KIDS|Orthopediatrics|$22.18|3.64%|$44.69 million||20240331|\n",query_data:{number:l,title:A,query_type:z,condition:a,model_sql:H,data_ext_params:{merge_repeat:c,expand_index:b,data_add:l,add_index:f}}}],answer_chain_name:I,agent_mode:J,native_answer:a,come_from:a,text_answer:G,trace_id:g,cost:21214,event_names:a,question:e,fallback_type:K,input_type:L,fall_back_reason:{fall_back_type:K,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:g,first_return_cost:3364,cache_type:"no_cache",question_id:g,transfer_question:e,signal_type:"ON_COMPLETE",start_time:B,remote_svc:j,slots:[],answer_type:y,user_id:t,skill_name:C},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:g,session_id:g,user_id:t,question:e,source:j,raw_question:e,version:"3.4.1",action_name:C,nlu:{entity:[{type:M,value:"KIDS.O",market:N}]},output_time:B,deep_research:c,deep_thinking:c,agent_mode:J},extra:{}},{answer_path:u,section:{id:v,info_texts:["Thinking"],show_type:w,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:u,section:{id:v,info_texts:["Querying Stock: KIDS Revenue (FY), Expenses (FY) in Q4 2024 and the three preceding quarters"],show_type:w,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"thinking"},logs:[],extra:{action:"Querying Stock",action_input:A,thought:"The user wants to compare the revenue and expense performance of KIDS in Q4 2024 with previous quarters. I should focus on the company's financial data, specifically the revenue and expense data for Q4 2024 and the three preceding quarters. I will use FinQuery for the data mentioned above."}},{answer_path:d,section:{id:m,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:u,section:{id:v,info_texts:["Generating Answer"],show_type:w,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:n,info_texts:[],show_type:o,voice_txt:"Orth",text_answer:O,rich_text:O,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:o,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:A,query_type:z,trace_data:a,index:l,model_sql:H,data_ext_params:{merge_repeat:c,expand_index:b,data_add:l,add_index:f},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:n,info_texts:[],show_type:o,voice_txt:D,text_answer:D,rich_text:D,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"KIDS",market_id:N,name:P,domain:M},pos:f,section_id:n,txt:P,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:n,info_texts:[],show_type:o,voice_txt:".",text_answer:Q,rich_text:Q,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:n,info_texts:[],show_type:o,voice_txt:"\n",text_answer:R,rich_text:R,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:u,section:{id:v,info_texts:["Completed"],show_type:w,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:p,query_text:p,trace_info:{item_id:"bcfdc8c0fa775f555ded0bede1e10c72",item_type:i,item_name:p,rec_info:S}},{display_text:q,query_text:q,trace_info:{item_id:"192663db5cf2e37e2fe8f9309e7fdec8",item_type:i,item_name:q,rec_info:T}},{display_text:r,query_text:r,trace_info:{item_id:"3a0ac67105d2e735a409755c32e127d3",item_type:i,item_name:r,rec_info:U}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:c,txt_style:f,type:"1",display2:c,url:a}},request_config:[{source_type:V,related_name:W}],puuid:E,tag:a,category:"custom",uuid:X}],global:{urp_static_data:[{name:W,value:{status_code:f,columns:[{type:s,index_name:Y,key:Y},{type:s,index_name:Z,key:Z},{type:s,index_name:_,key:_},{type:s,index_name:$,key:$},{type:s,index_name:aa,key:aa}],datas:[{send_text:p,item_type:i,rec_info:S,display_text:p,rec_reason:a},{send_text:q,item_type:i,rec_info:T,display_text:q,rec_reason:a},{send_text:r,item_type:i,rec_info:U,display_text:r,rec_reason:a}],dataSize:V,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:ab,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:x,"min-height":"100%",position:ac,height:x},isMaterial:c,id:ab,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:f,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:F,componentUuid:X,script:[{name:ad,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:F,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:F},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:x,position:ac,height:x},isMaterial:b,_id:19,id:ad,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:ae,voice_txt:a,tracking_info:{},uuid:E},order:{is_auto:c,render_for:ae,chart_type:"command",puuid:E}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:C,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:y,answer_chain_name:I},is_deep_research:c,deep_thinking:c,create_time:1746681209588},is_last:b}],questionItem:{data:{qStr:e,encodeFlag:c,imageData:k,docsData:[],quoteData:k},tplType:"question"},events:af,agentId:a,param:{entity_info:{},add_info:{ori_question:e},event_list:af,client_ip:a,question:e,user_id:t,user_name:a,trace_id:g,session_id:g,source:j,input_type:L}}],userId:t,userName:a,startTime:B,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:k,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:f,traceTableData:k,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-kids-revenue-and-expenses-trend-in-q4-2024-compared-to-previous-quarters-291a45\u002F",config:{_app:{basePath:ag,assetsPath:ag,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer","How did KIDS' revenue and expenses trend in Q4 2024 compared to previous quarters?",0,"062f0868-a036-4671-809f-2566b3000a19","signal","llm_generated","ths_ainvest_lite_web",null,1,999,2001,"rich_text","What was the EBITDA margin for KIDS in Q4 2024?","What was the net income of KIDS in Q4 2024?","What were KIDS' revenue figures for Q4 2024?","STR","dp64844711","progress\u002Fsearching_for",1000,"searching_for","auto","agent","intusstock","KIDS Revenue (FY), Expenses (FY) in Q4 2024 and the three preceding quarters",1746681188374,"inspect stocks",":\n\n1","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Orthopediatrics (KIDS) showed a general upward trend in revenue and a slight increase in expenses from Q1 2024 to Q4 2024:\n\n1. **Revenue Trend**: The revenue for Q1 2024 was $44.69 million, and it increased to $97.49 million by Q2 2024. A significant jump was observed from $152.06 million in Q3 2024 to $204.73 million in Q4 2024, indicating a strong revenue growth in the last quarter of the year.\n2. **Expense Trend**: The expenses also showed an increasing trend over the same period, starting from $44.69 million in Q1 2024, rising to $97.49 million by Q2 2024, and then to $152.06 million by Q3 2024. However, the increase in expenses was more gradual compared to the revenue growth, as the Q4 2024 expenses were similar to those in Q3 2024.\n\n\n\nThe data suggests that while Orthopediatrics experienced steady growth in both revenue and expenses throughout 2024, the most significant increase in revenue occurred in Q4 2024, outpacing the increase in expenses, which may have contributed to the company's profitability at the end of the year.","select   stock_code,   total_revenue_cum,   total_expenses_cum from   ustock_fin_data where   report_end_date = range ('2024y4q-3q', '2024y4q')   and stock_code = 'KIDS.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","185","Orthopediatrics (KIDS) showed a general upward trend in revenue and a slight increase in expenses from Q1 2024 to Q4 2024[^1]","Orthopediatrics",". **Revenue Trend**: The revenue for Q1 2024 was $44.69 million, and it increased to $97.49 million by Q2 2024. A significant jump was observed from $152.06 million in Q3 2024 to $204.73 million in Q4 2024, indicating a strong revenue growth in the last quarter of the year.\n2. **Expense Trend**: The expenses also showed an increasing trend over the same period, starting from $44.69 million in Q1 2024, rising to $97.49 million by Q2 2024, and then to $152.06 million by Q3 2024. However, the increase in expenses was more gradual compared to the revenue growth, as the Q4 2024 expenses were similar to those in Q3 2024.\n","\n``` visual\n{\"uuid\":\"c51ddbc7-97af-4729-9591-270bb716b9ea\"}\n```\n\nThe data suggests that while Orthopediatrics experienced steady growth in both revenue and expenses throughout 2024, the most significant increase in revenue occurred in Q4 2024, outpacing the increase in expenses, which may have contributed to the company's profitability at the end of the year.","2+679_496_21_554+0+0+062f0868-a036-4671-809f-2566b3000a19+bcfdc8c0fa775f555ded0bede1e10c72+llm_generated+aimeTagAnalysis+0+0.029376478865742683+1","2+679_496_21_554+0+0+062f0868-a036-4671-809f-2566b3000a19+192663db5cf2e37e2fe8f9309e7fdec8+llm_generated+aimeTagAnalysis+0+0.02712005190551281+2","2+679_496_21_554+0+0+062f0868-a036-4671-809f-2566b3000a19+3a0ac67105d2e735a409755c32e127d3+llm_generated+aimeTagAnalysis+0+0.024617524817585945+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>